The IL‐1β Converting Enzyme as a Therapeutic Target
- 1 November 1993
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 696 (1) , 133-148
- https://doi.org/10.1111/j.1749-6632.1993.tb17148.x
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Interleukin-1 receptor antagonist: Discovery, structure and propertiesPublished by Elsevier ,2004
- A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infectionCell, 1992
- Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding proteinCell, 1992
- Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzymeCell, 1992
- A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytesNature, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Biologic effects of an interleukin‐1 receptor antagonist protein on interleukin‐1–stimulated cartilage erosion and chondrocyte responsivenessArthritis & Rheumatism, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cellsEuropean Journal of Immunology, 1989
- Activation of interleukin‐ 1β by a co‐induced proteaseFEBS Letters, 1989